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Abstract
Introduction—A primary mission of the U.S. Centers for Disease Control and Prevention's 
(CDC) is promoting immunization against seasonal influenza. As with most education efforts, 
CDCs influenza-related communications are often informed by formative research.
Methods—A qualitative meta-analysis of 29 unpublished, primarily qualitative CDC-sponsored 
studies related to flu and flu vaccination knowledge, attitudes and beliefs (KABs). The studies, 
undertaken between 2000 and 2013, involved focus groups, in-depth interviews, message testing 
and surveys. Some involved health care professionals, while others involved members of the 
public, including sub-populations at risk for severe illness.
Findings—The themes that emerged suggested progress in terms of KABs related to influenza 
and influenza vaccination, but also the persistence of many barriers to vaccine acceptance. With 
respect to the public, recurring themes included limited understanding of influenza and 
immunization recommendations, indications of greater sub-group recognition of the value of flu 
vaccination, continued resistance to vaccination among many, and overestimation of the 
effectiveness of non-vaccine measures. Seven cognitive facilitators of vaccination were identified 
in the studies along with six cognitive barriers. For health care providers, the analysis suggests 
greater knowledge and more favorable beliefs, but many misperceptions persist and are similar to 
those held by the public. KABs often differed by type or category of health care provider.
Conclusions—The themes identified in this qualitative analysis illustrate the difficulty in 
changing KABs related to influenza and influenza vaccine, particularly on the scope and scale 
needed to greatly improve uptake. Even with an influenza pandemic and more vaccine options 
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available, public and some health care provider perceptions and beliefs are difficult and slow to 
change. This meta-analysis does, however, provide important insights from previously 
unpublished information that can help those who are promoting influenza vaccination to health 
care providers, the general public and specific populations within the general population.
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Influenza; Health communication; Influenza vaccination; Influenza knowledge, Attitudes and 
beliefs (KABs); Communication research; Vaccine promotion
1. Introduction
Increasing the number of people vaccinated each year against seasonal influenza is a goal of 
many public and private health programs in the United States and a growing number of 
countries [1–5]. In the United States, seasonal influenza is a disease that causes substantial 
illness, hospitalizations and deaths every year [5–8], and leads to death from other causes, 
such as pneumonia or congestive heart failure [7,8]. Seasonal influenza places adults aged 
65 years old and older, children, pregnant women, and persons of any age who have chronic 
medical conditions like asthma, diabetes and obesity at higher risk for serious illness and 
death [5,8]. The economic impact of influenza is also substantial, with one national study 
estimating the annual economic cost of seasonal influenza in the United States to be $87.1 
billion, including $10.4 billion in direct medical costs [8].
Annual influenza vaccination is the most effective way to prevent influenza and its 
complications, and as such, the past decade has seen the U.S. Advisory Committee on 
Immunization Practices (ACIP) greatly broaden flu immunization recommendations. Since 
the 2010–2011 influenza season, ACIP and CDC have recommended that all persons 6 
months old and older, unless medically contraindicated, should receive annual vaccination 
with the most up-to-date influenza strains [5]. Before 2010, only persons 50 years old and 
older, pregnant women, persons aged 18–49 years with medical conditions that place them at 
high risk for influenza complications, health-care personnel (HCP), and children aged 6 
months–17 years were recommended for annual vaccination [5,9]. Illustrating the 
importance of expanding the number of people who receive an annual influenza vaccination, 
the U.S. Healthy People 2020 goals call for 70 percent flu vaccine uptake among children 6 
months to 17 years, 70 percent among adults 18 and older, and 90 percent for HCP [1].
The broadening of influenza vaccination recommendations, greater public health recognition 
of the value of seasonal vaccination to pandemic influenza preparedness and response (e.g., 
the 2009 H1N1 response suggested higher seasonal flu vaccination rates may foster 
pandemic flu vaccination acceptance), and more concerted efforts to increase both HCP 
vaccination and flu vaccination efforts, have fostered some increases in influenza 
vaccination coverage in the U.S. A compilation of influenza vaccination coverage studies 
done over the course of 2007–2008 to 2011–2012 flu seasons, for instance, found modest to 
large increases in most groups [10]. Influenza vaccination coverage among children 6 
months to 17 years old increased from 31.1 percent in the 2007–2008 season to 56.7 percent 
in the 2011–2012 season while coverage during that period among adults 18 years old and 
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older increased from 33 percent to 38.3 percent. Coverage among HCP was around 62–67 
percent in 2011–2012 compared to around 48 percent in 2007–2008 [10]. Most recently, 
seasonal flu vaccination coverage estimates from the 2013–2014 season found 42.2 percent 
of adults 18 years old and older were vaccinated, with the rate among 6 month to 17 year-old 
children being 58.9 percent [11]. Overall, however, influenza vaccination rates in the United 
States are substantially below the Healthy People 2020 goals.
Achieving compliance with influenza vaccination recommendations and ultimately, higher 
influenza coverage requires more than expanding the recommendations. Adequate vaccine 
supplies, timely distribution, easy access to vaccine and health care provider involvement are 
critical. A strong infrastructure, in turn, usually also requires effective influenza vaccination 
promotion and communication, including messaging that takes into account the knowledge, 
concerns and beliefs of both targeted population(s) and the health care professionals counted 
on to recommend and provide the vaccinations—with the goal in both cases being to foster 
favorable attitudes and intentions [12–15]. Messages and materials that are not informed or 
guided by audience or population research not only decrease the likelihood of success, they 
can dissuade people from taking recommended actions. At the U.S. CDC, the Health 
Communication Science Office (HCSO) in the National Center for Immunization and 
Respiratory Diseases (NCIRD) is responsible for developing influenza vaccination-related 
communications, messages and materials—with those efforts designed to educate HCPs, 
assist HCP in patient education efforts, and persuade people in targeted groups to get an 
annual influenza vaccination.
For over a decade, NCIRD's HCSO has undertaken a variety of formative communication 
research-related projects with members of a number of different public population groups as 
well as with HCPs to inform its influenza vaccination promotion, communication and 
messaging efforts. This research has been essential given the ever-changing flu vaccine 
environment—which in the past decade has included vaccine shortages and delays, evolving 
and expanding recommendations, a pandemic, the occasional publication and publicizing of 
low flu vaccine efficacy estimates in seasons where there is a weak match between vaccine 
strain(s) and circulating strains, and a growing number of flu vaccine options, including 
nasal spray, intradermal, cell-based, high-dose, and quadrivalent formulations. Focus group 
discussions, in-depth interviews (IDIs), message testing and surveys have been used to learn 
more about how different groups perceive influenza and influenza vaccines, and to identify 
knowledge, attitude and beliefs associated with obtaining and not obtaining a seasonal 
influenza vaccination.
The value of communication-related research goes far beyond campaigns. Communication 
research can inform and strengthen: (1) how the benefits, value, and risk of recommended 
vaccinations are framed or presented to those people the recommendation encompasses 
[16,17]; (2) the messaging and messages used to inform people about a vaccine or 
immunization recommendation, including those provided to the public, HCPs and the media 
[18]; (3) patient and parent immunization education materials, including those provided or 
found in physician offices [17]; (4) how providers address parent or patient questions and 
concerns related to vaccines and vaccinations [19,20]; and (5) other actions, steps or policies 
that may need to be considered to overcome barriers to providing (e.g., by physicians) or 
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accepting a recommended vaccination (e.g., by members of a targeted population) [18,21]. 
Thus, even if a formal education or promotion campaign is not used as a strategy to increase 
vaccination uptake, the insights and understandings gained from communications research 
have significant value for many of the major components of immunization programs and 
efforts.
A number of recently published systematic reviews and meta-analyses illustrate both the 
value of communications-related research and ways in which insights into the KAB's of 
health care provider and consumer/public population groups are applied to influenza 
vaccination promotion. McDonald et al. used a systematic review of 22 published studies 
from seven European countries to identify effective practices in promotional 
communications (i.e., any message delivered through any channel with the intent to 
encourage or promote vaccination) [22]. While their review did not directly assess the 
impact of promotional communications on public acceptance of influenza vaccination, they 
found evidence that personalizing communications and having supportive health care 
workers could foster improved influenza vaccination uptake [22]. With respect to health care 
workers, Vasilevska, Ku and Fisman's [23] systematic review and meta-analysis of 37 
studies – 25 of which involved seasonal influenza vaccination – found several beliefs that 
appeared to be consistent predictors of vaccine acceptance. Health care workers were more 
willing to accept vaccination if they believed the vaccines were safe, would protect them and 
their families, and would not cause the disease they meant to protect against. The latter was 
a particular concern for influenza vaccines.
Wheelock, Thomson and Sevdalis [24] focused exclusively on seasonal influenza 
vaccination in their effort to identify social and psychological factors underlying adult 
vaccination. Their review of published studies involving seasonal flu vaccination in the U.S. 
and the U.K. identified eight themes – primarily categories of beliefs – that were linked to 
seasonal influenza vaccination uptake or refusal [24]. They found recommendations from 
health care professionals, close relatives or friends; perceived susceptibility to influenza; and 
perceived effectiveness of the vaccine were three primary facilitators of seasonal flu 
vaccination, while lack of awareness of the recommendation, belief that vaccine was 
ineffective or could cause influenza, and not perceiving influenza as a health threat inhibited 
vaccination. They also found the KABs of health care professionals were often similar to 
those of the public. Finally, a recently published systematic review of 21 studies involving 
pregnant women and influenza (including 13 involving influenza A/H1N1 pandemic 
vaccination), identified lack of awareness of the recommendation, underestimation of the 
threat posed by seasonal flu, and concerns related to vaccine safety as KABs linked to 
vaccination uptake or refusal [25]. The study also found HCPs' recommendations fostered 
uptake but many did not recommend the vaccine to their pregnant patients.
Along with highlighting the value of systematic reviews of studies involving KABs and/or 
communication research, the examples above illustrate the value of doing such an 
assessment of the NCIRD HCSO unpublished communication research-related studies. 
McDonald et al., for instance, noted that the current evidence base for effective promotional 
communications is “fragmented and incomplete,” with more information needed to inform 
messages and messaging [22]. They also noted that there are few published studies designed 
Nowak et al. Page 4
Vaccine. Author manuscript; available in PMC 2018 March 16.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
to obtain information that could provide the basis for evidence-based communication. 
Similarly, Yuen and Tarrant [25] noted that the “gray literature” (i.e., unpublished research 
studies) may have value for those seeking to increase seasonal influenza vaccination among 
targeted groups but such studies are often difficult to find or access. Thus, an important 
feature of this study is that it brings forth information and insights from a relatively large 
“gray literature” database.
2. Methods
The qualitative meta-analysis undertaken sought to accomplish three objectives: (1) to make 
available the key findings from a “grey literature” of 29 unpublished seasonal influenza 
vaccination communications research-related studies conducted over a 14-year span by the 
Health Communication Science Office in CDC's NCIRD; (2) to characterize the key KAB-
related themes and findings from those studies, which included an influenza pandemic, 
expanded vaccination recommendations, and increased/new influenza vaccine options (e.g., 
a nasal mist vaccine, a higher dose vaccine, an intradermal vaccine, cell-based vaccine, and a 
quadrivalent vaccine); and (3) highlight some of the ways in which these themes and 
findings intersect with seasonal influenza-related promotion, communication and messaging 
efforts. These objectives support the broader goal—which is to assist those designing or 
undertaking communication, education or promotional efforts to increase seasonal influenza 
vaccination, including by and among health care professionals. As a recently published 
World Health Organization (WHO) guidance notes, active promotion and communication 
efforts are more likely to succeed when informed by population and stakeholder research 
[17]. These studies, which were designed to inform promotion, communication and 
messaging efforts, were undertaken between 2000 and 2013. The need to rapidly integrate 
findings into campaign plans and materials, ongoing communication challenges and issues, 
and limited resources precluded publishing findings from the individual studies.
A qualitative meta-analysis is a secondary analysis of primary qualitative and mixed 
methods studies [26]. It generally follows the same procedures as quantitative meta-analysis 
but instead of a statistical data analysis the researcher analyzes textual reports and seeks to 
identify major themes, including over time and across different studies [27]. In this case, the 
meta-analysis used the final or summary reports prepared by the contractors who undertook 
the studies as the basis for the analysis (e.g., the Oak Ridge Institute for Science and 
Education, American Institutes for Research). These reports identified key themes and 
findings, illustrative comments, and provided a qualitative sense of whether most, many or 
some of the participants held a particularly belief or perspective. Two of the authors 
independently focused on identifying the themes related to influenza and influenza 
vaccination knowledge, attitudes and beliefs.
Most of the studies were qualitative, with 13 exclusively involving focus group discussions, 
six exclusively involving in-depth interviews (IDIs) and four involving both in-depth 
interviews and focus groups. There were also seven studies that utilized survey research, 
including one that involved message testing. Table 1 provides the report titles and year, 
communication research method(s), and target audience(s) involved in the research. An 
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“identifier” assigned to each study is also provided in Table 1, with this identifier used in the 
research syntheses shown in the tables found in Section 3.
As Table 1 indicates, the research encompassed a range of target populations/audiences. 
Fifteen of studies included participants from different public or consumer targeted 
audiences, with ten involving adults 50 years old and older; seven involved parents, 
primarily mothers; five involved people with chronic medical conditions that put them at risk 
for influenza complications; and four involved national probability surveys of adults 18 
years old and older. Eight of the qualitative studies also included Hispanic American focus 
groups, while seven included African American focus groups. Eleven of the studies involved 
health care providers, with eight including physicians and six including nurses, physician 
assistants or other health care professionals. Across the studies, a wide range of other HCPs 
were included (e.g., administrative personnel, service workers, clinical workers). One study 
encompassed CDC employees. NCIRD HCSO studies exclusively related to 2009 H1N1 
influenza vaccination were not included in the meta-analysis—though two studies that also 
encompassed seasonal influenza were included.
3. Results
The major themes found in the meta-analysis are shown in Table 2 for the studies involving 
the general public, parents and targeted sub-populations of the general public. Table 3 
summarizes themes related to health care providers and professionals.
3.1. Basic but limited knowledge about influenza and influenza vaccination
Collectively, the analysis indicated that members of the public as well as HCPs had a basic 
understanding of influenza, including its major symptoms, its most common forms of 
transmission, its seasonality, and usual duration of illness. Across time and over studies, 
influenza was generally perceived as being different and more serious than the “common 
cold,” and as a contagious disease primarily transmitted during colder weather months. In 
line with this, many perceived cold weather as potentially causing influenza—e.g., by being 
inadequately dressed for the cold or going into the cold with wet hair. There did not appear 
to be significant racial/ethnic differences with respect to how influenza illness was 
perceived, though African American participants often noted hospitalization and death as 
serious outcomes from contracting influenza.
The meta-analysis suggested that overall awareness of influenza vaccine was high but that 
many individuals did not believe that seasonal vaccination pertained to them. Even as the 
influenza vaccination recommendation in the U.S. has been broadened to encompass almost 
everyone, the belief it pertains to specific groups, such as people 65 years old and older, 
people with chronic health conditions, weakened or weaker immune systems, and young 
children persisted for many. The studies done in the past few years suggested that people 50 
to 64 years old and people with chronic health conditions may have become more aware that 
they, too, should get a seasonal influenza vaccination.
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3.2. Seven facilitators of influenza vaccination
The meta-analysis suggested seven factors that appeared to be linked with getting a seasonal 
influenza vaccination or facilitated decisions to get a flu vaccination.
3.2.1. Perceived susceptibility or health threat—In comparing those who typically 
received seasonal flu vaccinations to those who did not (i.e., “doers” vs. “non-doers”), 
perceiving one's self as susceptible to influenza or believing that influenza was a significant/
serious health threat was a key difference. People who were 50 years old and older and/or 
who had a chronic medical condition that increased the likelihood of complications from flu 
generally believed influenza to be a significant health threat and sought vaccination as a way 
to reduce either the threat or the severity of influenza illness. Similarly, even parents who 
stated they were personally unconcerned about influenza indicated they had their children 
vaccinated.
3.2.2. Prevention/protection from influenza—Those who typically received a 
seasonal flu vaccination believed that vaccination would prevent flu or reduce the severity of 
the illness should they contract influenza, particularly those with chronic health conditions 
and people 50 years old and older. Some African American participants who received the 
vaccine did not believe it would prevent people from contracting influenza but made the 
symptoms less severe. In the case of parents, many stated they believed the vaccine would 
protect their children from influenza, with this especially being the case for parents of 
children at risk for flu complications.
3.2.3. Age and health status—Age and health status were also often associated with 
seasonal flu vaccination. Both vaccination rates and belief in the value/benefits of influenza 
vaccination increased with age and with the onset of chronic health conditions that placed 
one at risk for flu complications. Conversely, younger and self-reported “healthy” 
participants were less likely to see a need for seasonal flu vaccination.
3.2.4. Health care provider recommendation—Collectively, these studies reaffirmed 
the central role that health care providers, particularly physicians (including Ob/GYNs and 
other specialists) play when it comes to influenza vaccine acceptance. Many individuals, 
including parents, relied on physicians, pediatricians and specialists for information and 
guidance, and many cited a physician recommendation as their reason for getting themselves 
or their child vaccinated. However, two surveys conducted during the 2007 flu season – one 
a national telephone survey, the other a web-based panel – found that around 65 percent of 
all respondents said a physician or other health care professional did not discuss getting a 
seasonal flu shot with them. Among respondents 65 and older, about half reported having 
such a conversation. In addition, some studies did find that some Hispanic and African 
American participants believed doctors recommended unnecessary vaccinations such as 
influenza as a way to make a profit. None of the studies found evidence that patients or 
parents inquired or were interested in the flu vaccination status of their health care providers
—though this was not an issue that was ever explicitly explored.
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3.2.5. Experience with influenza illness—Most people who had personally 
experienced a severe case of influenza or knew of a family member or friend who had 
experienced severe influenza illness were likely to get vaccinated in subsequent years. Many 
said they did not want to repeat that experience, particularly those who had chronic medical 
conditions that may have increased the severity of their symptoms or the duration of their 
illness.
3.2.6. Convenience—Many individuals, particularly HCPs, noted they had gotten 
vaccinated, and were more likely to get vaccinated, when the vaccine was readily available, 
such as in their workplace, and free. Others noted that when they were not able to easily find 
vaccine or when they had to wait in a long line they decided against vaccination. Overall, the 
cost of influenza vaccination was rarely mentioned in any of the studies, including a barrier 
to vaccination. However, some participants in studies involving antiviral medicines, 
including health care providers, did note that the cost of prescription drugs was sometimes a 
consideration in their use.
3.2.7. Active promotion—In testing materials and messages, studies found that visible 
and frequent reminders, public service announcements or advertising in the media, and 
media news stories helped foster vaccination. People indicated that the information 
encountered in message testing studies was often helpful—and also often not previously 
known. These studies suggested that many people found having simple, easy-to-understand 
information about why people like themselves should receive a seasonal flu vaccination was 
helpful. Many people, including HCPs, desired information about vaccine safety, side effects 
and vaccine effectiveness – particularly information specific to their age, health status or 
occupation.
3.3. Six barriers or inhibitors of seasonal influenza vaccination
The themes shown in Tables 2 and 3 also suggested six barriers or inhibitors of seasonal 
influenza vaccination, with most of these barriers also applying to those HCPs who typically 
declined seasonal flu vaccination.
3.3.1. Not susceptible to serious illness/influenza is a “manageable” illness—
Many who did not get a seasonal flu vaccine, and some HCPs, believed that they were not 
likely to experience a severe course of influenza illness and/or that influenza was a 
“manageable” disease. This was especially true for individuals who believed themselves or 
their children to be in good health or have a “strong immune system.” For these individuals, 
seasonal influenza vaccination was either “not necessary” or “optional.” Many 
acknowledged that influenza was more than a “bad cold” but simultaneously believed it was 
an illness of manageable duration and tolerable symptoms. These sentiments were also 
expressed by some HCPs, including those who recommended vaccinations for at-risk 
patients.
3.3.2. Flu vaccine recommendations do not apply to me—Overall, the meta-
analysis indicated many did not know or believe that influenza vaccination recommendations 
encompassed people like themselves. “I don't think I need it” was the most commonly stated 
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reason by people who did not get a seasonal flu vaccination. Rather, many individuals, 
particularly those under age 50, perceived that flu vaccination recommendations primarily 
pertained to people over 65, people with weak or weakened immune systems, and young 
children- and it was people in those groups who needed and benefitted from vaccination. 
Many younger and self-reported “healthy” individuals did not believe that a much broader 
population needed a seasonal influenza vaccination. Some individuals with chronic 
conditions believed that by effectively managing their condition they did not need a seasonal 
flu vaccination, while some nurses believed that influenza vaccination was necessary only 
for “older nurses.”
3.3.3. Influenza vaccines are not effective—Many people in the national surveys 
indicated that they did not believe the vaccine would protect them from influenza (e.g., from 
1 in 5 to 1 in 3), while many individuals in the qualitative studies stated that sentiment. 
Parents who declined vaccination for their children also often cited vaccine ineffectiveness. 
The fact the flu strains in the vaccine often varied from year to year was evidence to some 
that the vaccine could not be very effective.
3.3.4. Fearful of concerned about, influenza vaccines—Some individuals, 
including those who routinely received a seasonal flu vaccination, believed the vaccine could 
leave them susceptible to influenza or flu-like illnesses. Others, including many African 
American participants, believed that flu vaccines were highly likely to cause bad side effects 
or adverse reactions. In all instances, these individuals believed negative consequences were 
more likely than positive outcomes. Others were concerned about how flu vaccines could 
interact with antibiotics and other prescription medicines.
3.3.5. Other measures are as or more effective than vaccination—Many who 
declined seasonal flu vaccination, along with some who did get vaccinated, believed that 
other measures were as or more effective when it came to preventing flu. In general, having 
or maintaining a “healthy immune system” was seen by many as the most effective way to 
prevent influenza. Many adults also cited their habit of not getting a seasonal flu vaccination 
as effective, and noted that they were “doing fine without it” or “did not want to mess with a 
good thing” (i.e., not getting vaccinated).
3.3.6. Personal experience with influenza or influenza vaccination—As with 
people who regularly got a flu vaccination, people who did not routinely get an influenza 
vaccination cited personal experience with influenza or influenza vaccine as a reason for 
declining vaccination. People who had what they characterized as a “manageable” illness 
often believed that their experience was typical when it came to influenza. Thus, while the 
illness caused discomfort and notable symptoms for a number of days, their ability to fight 
through it left many confident they could handle future bouts of influenza.
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4. Evolution and challenges in the realm of health care providers and 
professionals
As Table 3 illustrates, the studies involving HCPs often found beliefs and sentiments similar 
to those held by the general public and public sub-populations. Health care professionals 
were often very knowledgeable about high-risk populations that should be vaccinated, but 
less likely to be aware or appreciate that they were among the high priority group—with this 
especially being the case in studies done before the ACIP universal vaccination 
recommendation (i.e., when HCPs were among the relatively few groups singled out for 
annual flu vaccination). Similar to many in the public, HCPs often characterized influenza as 
a manageable illness for healthy people and also saw seasonal flu vaccination as optional. 
Even though they worked in environments that put them at risk for influenza, many did not 
see influenza as a significant personal health threat and believed they could “handle it.” 
Some were also fearful the vaccine could cause them to become ill or leave them susceptible 
to illness.
Also notable was that some HCPs did not believe that they posed a significant influenza 
transmission threat to patients, including infants and children. Rather, these individuals 
perceived patients as the likely conduits of influenza. In line with this, some nurses and 
allied health professionals noted that flu vaccines were a mechanism to protect themselves 
from patients rather than as a means to protect patients. Only one of the studies explicitly 
addressed vaccine mandates (IDIFG3). In this study, hospital administrators noted none of 
their institutions mandated influenza vaccination, but it was noted that “vigorous efforts” 
appeared to increase vaccination rates. Not surprisingly, health care workers who did not get 
influenza vaccinations were not supportive of mandates, including because of distrust of the 
vaccine's safety and effectiveness and/or because of distrust of the institutions involved. A 
study that involved health care worker education materials found messages that focused on 
self, patients and families resonated best, while those that induced guilt or mentioned 
missing work due to illness were not well received (IDIFG2).
5. Discussion
Collectively, the 29 studies analyzed here provide a wealth of information concerning the 
knowledge, attitudes and beliefs of the general public, specific sub-populations within the 
public and health care providers and professionals when it comes to seasonal influenza 
vaccination.
The findings suggest that during a period of significant developments and changes in the 
influenza vaccination landscape, incremental progress was made with respect to influenza-
related knowledge, attitudes and beliefs, on both the public and HCP fronts. There were 
indications that more members of the public who are at highest risk of complications have 
become aware they should receive an annual vaccination and more likely to recognize that 
their age and/or health conditions place them at elevated risk of complications. More parents 
also appear aware of flu vaccination recommendations for children and more appear to 
believe there is a benefit to vaccination, particularly those with younger children or children 
who have a health condition that places them at risk for severe illness. The studies involving 
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HCPs, particularly physicians, provided additional evidence of such progress as many 
indicated they believed in flu vaccination for those in at-risk groups and often placed 
emphasis on vaccinating people in those groups. Most significantly, though, the national 
surveys included here also suggested that more older and at-risk adults and parents are 
heeding the seasonal flu vaccination recommendation – though clearly at modest, rather than 
desired levels.
Along with evidence of progress, the meta-analysis reaffirmed many of the challenges and 
barriers identified in previous studies [14,22–25]—as well as provided additional evidence 
of the persistence of many of the cognitive barriers to seasonal influenza vaccination. Many 
people, both in the public/parent population and in the HCP groups, remain unconvinced of 
the need for seasonal influenza vaccination and unpersuaded that the benefits provided 
outweigh the risks and costs they associate with the vaccine. Further, and as one study noted 
(i.e., IDIFG3), many of those who decline seasonal influenza vaccination for themselves or 
their children have “defense in depth.” Often drawing upon personal experience, their 
expectation is that influenza will not pose a significant or serious health threat to them and 
should they contract it, they assume it will be a manageable illness. Not surprisingly, their 
expectations and assumptions also support their conclusion that they do not need seasonal 
flu vaccine. Such beliefs are challenging on two fronts.
One, the expectation and assumption are not unreasonable for many people, particularly 
healthy younger adults. While influenza is unpredictable, the percentage of people in the 
U.S. who contract flu each year ranges from 5 percent to 20 percent [28]. While more than 
200,000 people are hospitalized each year and estimates of flu-associated deaths in the U.S. 
range from a low of about 3000 to a high of about 49,000 [5–7], it is likely that most people 
will not personally experience an unusually severe illness from influenza in a typical year. 
Unfortunately, the ability of one's immune system to “manage” influenza can only be known 
after the fact (i.e., after one has recovered) and all those who are infected with influenza can 
transmit it to others, including young children, people 65 and older for whom vaccination 
generally works less well, people with weak or weakened immune systems, chronic health 
conditions, and pregnant women. Thus, as the communication research studies assessed here 
illustrate, it is vital that promotion efforts and messages address the superficial 
understanding that many have regarding influenza and the role that vaccination plays in 
protecting more than the individual who receives the vaccine. It is equally vital that 
communication research be undertaken on a regular basis to determine which messages 
work best and whether an impact is being made on KABs and intentions.
The themes uncovered in this meta-analysis also make clear that those interested in 
promoting influenza vaccination need to recognize that how people make vaccination 
decisions is similar to how they make other health and medical decisions. Recent studies on 
health and medical decision making, for instance, have found that risks create feelings, and 
as result, even well informed patients make medical decisions or perform health behaviors 
that are at odds with health experts' advice [29]. In such cases, people often default to an 
“affect” heuristic (i.e., cognitive shortcut) where they presume that the risks are low for risks 
associated with things they like and that the reverse is true for things they do not like [30]. In 
line with this, the meta-analysis conducted here found many adults reacted positively to flu 
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vaccination messages that encouraged vaccination as a way to be proactive, maintain a 
healthy lifestyle or protect loved ones. Much of NCIRD's HCSO flu vaccination promotion 
has sought to do this by identifying, linking and highlighting empowerment and positive 
outcomes with influenza vaccination. For those who are predisposed to vaccination, this 
serves to reaffirm the value of prevention. For those who are disinclined to vaccination, it 
can help increase their awareness that flu vaccination is consistent with things they like—
such as “building and maintaining a healthy immune system” or protecting family members, 
friends and people vulnerable from potentially serious illness.
Also in line with recent studies on health and medical decision making, this meta-analysis 
clearly found that people's views on disease severity, vaccine effectiveness and vaccine 
reactions are often more rooted in personal experience or stories from social networks rather 
than population-level statistics [31,32]. Thus, not surprisingly, many people responded most 
favorably to communication materials and messages that resonated with their life 
experiences (e.g., testimonials) as well as stated a preference for materials and messages 
tailored to their lives. As Table 2 showed, people want information that addresses their 
specific needs, concerns and questions—and this includes HCPs. Time and again, these 
studies found that members of the general public, parents, people with chronic medical 
conditions, HCPs and pregnant women often want information on: (1) why they are 
personally at risk for influenza or flu-related complications; (2) what the likely flu vaccine 
side effects and adverse reactions could be; (3) how likely they are to experience side effects 
or a serious adverse reaction; (4) how effective the vaccine is going to be; and increasingly 
(5) which of the various types of influenza vaccine are “the safest,” “most effective,” and 
“best for me”? That said, it also needs to be noted that for some people, the level or type of 
evidence they want may not exist—and that can and does hamper persuasion.
Finally, the meta-analysis findings not only reaffirm the central role that physicians and 
other HCPs play when it comes to seasonal influenza vaccination acceptance, they highlight 
the need for continued efforts to facilitate and assist on the patient and parent education 
front. One need is HCP training, particularly that which helps nurses and allied health 
professionals better understand the health threat posed by influenza, the ease in which 
influenza can be transmitted in health care settings, the vulnerability of patients in health 
care settings, the realities of the human immune system, how influenza vaccine interacts 
with the immune system, and the value of flu vaccine even if it cannot consistently provide 
complete protection from influenza. HCPs also need to recognize that their personal beliefs 
and behaviors can and do communicate to patients and parents, and if they place a low 
priority on vaccination it is likely their patients will as well.
It is also clear, however, that it should not be expected or assumed that HCPs, including 
specialists, can devote more time to patient education and conversations. As such, it is 
important to develop, provide and assess protocols and tools that can make patient education 
more effective and efficient. For example, one way NCIRD has applied the lessons learned 
from this research is the “SHARE” framework (Table 4) (http://www.cdc.gov/vaccines/hcp/
patient-ed/adults/downloads/standards-immz-practice-recommendation.pdf). This 
framework takes into account many of the themes uncovered in the meta-analysis in order to 
foster more effective vaccine-related communication. In addition to templates like this, 
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consideration should be given to using new and interactive technologies to foster parent and 
patient education; for example, via interactive websites, tablets and smartphones or other 
resources in the office setting. These can help meet the need for tailored and targeted 
information and messages.
It is recognized that this meta-analysis has limitations. First, it should be noted that the 
findings from the qualitative research studies are, by nature, neither quantifiable nor 
generalizable to the population as a whole. It is thus not known how many or what 
percentages of the different populations encompassed by these studies have the knowledge, 
attitudes or beliefs that were identified. While national survey data do provide good 
estimates of influenza vaccination behavior, it would also be helpful for future studies to 
quantify some of the KABs uncovered here. Second, the meta-analysis here was not guided 
by a specific or predetermined theoretical framework. It can help to have a specific theory or 
theoretical framework guide a systematic review or meta-analysis [e.g., [33], which used 
Protection Motivation Theory as a guide]. Given the depth, breadth and scope of the 
communication studies undertaken here (e.g., encompassing general public, sub-populations 
of the public and different categories of HCPs), it was felt a broader, less restrictive 
approach would be more effective in uncovering recurrent themes and allowing for 
comparisons between public and HCPs studies. A third limitation is the influenza 
vaccination environment or landscape. Over the course of the 14 years in which these studies 
were conducted, there were flu vaccine shortages and delays, expansion of flu vaccination 
recommendations, an influenza pandemic, publication and publicity of studies finding 
relatively low flu vaccine efficacy, and the introduction of a number of new products. These 
developments both created the need for ongoing communication research studies (including 
to guide the development of materials and messages), and also made it difficult to 
distinguish the impact of promotional communication efforts from other factors and 
information sources (e.g., news stories). That said, the fact that many KABs persisted across 
major events suggests that it may take further breakthroughs or advances in flu vaccine 
technology to achieve more than incremental progress in flu vaccine uptake. Finally, despite 
the breadth of these studies, many important groups, such as pregnant women, were not well 
represented. This highlights the importance of ongoing formative research studies.
Despite these limitations, the findings from this meta-analysis should provide helpful 
direction and guidance to those promoting and communicating about seasonal influenza 
vaccination. Programs can use the eight themes associated with seasonal flu vaccination in a 
number of ways to guide their communication strategies and efforts—from guiding 
communication objectives to identifying target populations to honing messages for those 
populations. Similarly, those seeking to persuade people or groups who are hesitant or 
disinclined to get a seasonal flu vaccination should find the insights surfaced here helpful. 
These groups will likely remain difficult to persuade, but this study's findings show the 
challenges that will need to be overcome in order to achieve success.
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Table 1
Communications-related research studies, Health Communication Science Office, National Center for 
Respiratory Diseases, U.S. CDC, 2000-2014.
Research method(s) Study identifier and report title Report year Target audience(s) and methods summary
Focus Groups (FG) FG1—Prevention and Treatment of 
Influenza in High Risk Adults
2014 Three focus groups were conducted with high-risk 
adults in Fort Lauderdale, FL; Chicago, IL; and 
Phoenix, AZ
• 23 high-risk adults, averaging 46 
years of age, participated
• High-risk conditions included 
asthma, chronic obstructive 
pulmonary disorder (COPD); 
diabetes and heart disease
FG2—Formative Research: Older Adults' 
Perceptions about Seasonal Influenza and 
Vaccine Effectiveness
2014 Nine 90-minute focus groups were conducted with 
adults 65 years of age and older. Focus groups 
were conducted at commercial market research 
facilities in Fort Lauderdale, Florida; Chicago, 
Illinois; and Phoenix, Arizona. A total of 61 
adults, averaging 70 years of age participated in 
this study
FG3—Focus Group Research Report: 
Quadrivalent Vaccine and Vaccine 
Effectiveness Messages
2013 Twenty focus groups—14 online and 6 in-person 
(Nashville, TN and Baltimore, MD). 122 
participants.
• Parents of children 6 months 
through 17 years old
• At-Risk adults aged 50–64 (i.e., 
adults with chronic diseases)
• Adults aged 65–80 years old
• All participants had received a flu 
vaccination at least once in past five 
years
FG4—Communication and Social 
Marketing to Promote Seasonal and 
Emergent Influenza Immunization for 
Hispanics: H1N1 and Seasonal Influenza 
Focus Group Final Report and Hispanic 
Risk Communications Model
2010 Six focus groups with Hispanic Americans aged 
19–50; 51 participants.
• Three groups with Hispanic parents 
of children 0–4 years of age in 
Miami, Los Angeles, and 
Greenville, NC
• Three groups with 18–24 year-old 
single Hispanics in Miami, Los 
Angeles and Greenville, NC
Focus Groups (FG) FG5—Communicating about Influenza 
Vaccination: Formative Research with 
Parents, Young Adults, Older Adults, and 
People with Asthma or Diabetes
2010 64 in-person focus groups of 4–6 participants each 
conducted in six cities: Indianapolis, IN; 
Baltimore, MD; Phoenix, AZ; Chicago, IL; 
Miami, FL; and Birmingham, AL.
• 20 groups with mothers of children 
of similar age-0–4 years old, 5–10 
years old, and 11–18 years old
• 18 groups with people 25–49 years 
of age living with asthma and/or 
diabetes
• 18 groups with adults aged 65–75 
years of age
• Six groups with young adults 19–24 
years of age
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Research method(s) Study identifier and report title Report year Target audience(s) and methods summary
FG6-Influenza Perception and Prevention 
Qualitative Research Topline Report of 
April 2009 Focus Group
2009 Six mini-focus groups conducted in Dallas, TX;
• A total of 16 adults aged 65 years 
and older participated
• A total of 10 mothers of 5-to 10-
year-old children participated
FG7—Seasonal and Novel H1N1 Influenza 
Vaccine Message Testing: Topline Report of 
June 2009 Focus Groups
2009 Fifteen focus groups were conducted with mothers 
of 5–10 year-old children in New York City, 
Chicago and Atlanta. 139 participants.
• Five groups with African American 
mothers
• Five groups with Caucasian 
mothers
• Five groups with Hispanic 
American mothers
• Eight groups had mothers with an 
associate's degree or less; seven 
groups had mothers with a 
bachelor's degree or more
FG8—Materials Testing of Influenza 
Vaccine Education Items: Topline Report
2005 Thirty focus groups were conducted with adults 
aged 50–64 in Philadelphia, Chicago, Houston and 
Oakland. 259 participants.
• 10 with African Americans, 
including 5 with males
• 10 with Caucasian Americans, 
including 5 with males
• 10 with Hispanic Americans, 
including 5 with males
FG9—Qualitative Research on Flu Vaccine 
Beliefs among Parents of Children under 
Two
2004 Ten focus groups were conducted with parents of 
children under two in Atlanta and Minneapolis. 78 
participants
• Four groups with Caucasian parents
• Three groups with African 
American parents
• Three groups with Hispanic 
American parents
• Half groups had household incomes 
above the media for their group, 
while half had household incomes 
below
Focus Groups (FG) FG10—Nurses Study Focus Groups in 
Birmingham, AL and Detroit, MI
2003 Eight focus groups with registered nurses with at 
least one year of clinical experience in 
Birmingham, AL and Detroit, MI. 71 participants
• Four groups with nurses who had 
received an influenza vaccination in 
past 14 months (i.e., “Doers”)
• Four groups with nurses who had 
not received an influenza 
vaccination in past 14 months (i.e., 
“Non-doers”)
FG11—Adult Immunizations Focus 
Groups: African-American Seniors from the 
Delta Counties of Mississippi
2003 Eight focus groups with African Americans aged 
65 years or older in Clarksdale, Greenwood and 
Yazoo City, MS. 63 participants
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Research method(s) Study identifier and report title Report year Target audience(s) and methods summary
• Four groups with those “likely to 
get a flu shot this year”
• Four groups with those “unlikely to 
get a flu shot this year”
FG12—Influenza Immunization Study 2000 Twenty six focus groups with adults 50 years old 
and older in Newark, NJ; Houston, TX; 
Milwaukee, WI; Atlanta, GA
• All had chronic medical conditions 
that put them at risk for flu 
complications
• Nine groups with Caucasian 
Americans
• Nine groups with African 
Americans
• Eight groups with Hispanic 
Americans
In-depth Interviews (IDI) IDI1—Audience Research: Understanding 
the Health Care Provider Perspective
2014 In-depth interviews with 16 physicians and 12 
nurse practitioners/registered nurses, all of whom 
were involved in the care of patients with chronic 
medical conditions. IDIs were conducted in the 
South, Midwest and West regions
IDI2—Research-Based Flu Intervention 
Strategies Utilizing Travel Medicine and 
Aero-Clinics
2013 Audio recordings of 35 pre-travel consultations 
were made at 11 health care facilities throughout 
the Atlanta, GA, metro area. These facilities were 
primarily travel clinics and clinics operated by 
health departments. The recorded consultations 
involved 44 travelers and 14 health care providers 
(HCPs). Structured interviews were also 
conducted with 16 of these travelers and 10 of 
these HCPs
IDI3—Influenza Immunization among 
CDC Employees
2008 A total of 16 one-hour individual in-depth 
interviews with Atlanta-based CDC employees, 
none of whom was involved in research or 
program activities involving influenza
Research method(s) Study identifier and report title Year Target audience(s)
In-depth Interviews (IDI) IDI4—Physicians' Perceptions of Current 
Vaccine Issues
2008 A total of 33 physicians – 21 pediatricians and 12 
family practitioners – were interviewed 
individually. Each reported providing at least five 
infant immunizations per week. Interviews were 
conducted in Kirkland, WA; Austin, TX; 
Hollywood, FL
IDI5—Pretesting of Spanish Influenza and 
Pneumococcal Immunization Materials
2003 Forty interviews with Spanish-speaking seniors 
aged 65 and older in Chicago, IL and San 
Antonio, TX. Twenty had annual incomes above 
$30 K per year, while twenty were below. Twenty 
one were male and 19 were female.
IDI6—Interviews with Allied Health 
Professionals: Topline Report
2003 Nine individual in-depth interviews conducted by 
telephone with nurses and physician assistants in 
Dallas and Chicago to obtain information that 
could be used in the development of provider 
influenza vaccination patient education kit.
In-depth Interviews and 
Focus Groups (IDIFG)
IDIFG1—Prevention and Treatment of 
Influenza in High Risk Adults Summary 
Report
2012 Thirty-minute in-depth interviews with 35 primary 
care physicians and 20 focus groups with adults 
21–65 years old who reported having asthma, 
diabetes or COPD. Research took place in Boston, 
MA; Houston, TX; and San Francisco, CA. 142 
adults participated in the focus groups. • Ten focus 
groups with Caucasian American adults • Five 
focus groups with African American adults • Four 
focus groups with Hispanic American adults • One 
focus group with Asian American adults
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Research method(s) Study identifier and report title Report year Target audience(s) and methods summary
IDIFG2—Formative Research: 2010 
Influenza Vaccine Health Care Providers 
and Workers
2010 Thirty-minute in-depth interviews with 38 
physicians in a range of practices, including 17 
Ob/Gyns, 8 internal medicine, 4 family practice, 3 
pediatricians and 6 specialists and focus group 
discussions with health workers, including 33 
registered nurses, 7 licensed practical nurses, 35 
hospital service workers and 23 allied health 
professionals in Hollywood, FL; Chicago, IL; San 
Francisco
In-depth Interviews and 
Focus Groups (IDIFG)
IDIFG3—A Qualitative Assessment of 
Factors Influencing Immunization of Health 
Care Workers
2007 Individual in-depth interviews with 12 
administration personnel-people who reported 
themselves personally involved in decisions 
regarding vaccination of hospital personnel–along 
with IDIs or mini-focus group discussions 
involving 63 other clinical personnel who spent at 
least 50% of their time in contact with patients. 
Interviews and groups were conducted in New 
York City, Hollywood Beach, FL, Scottsdale, AZ 
and San Francisco, CA
IDIFG4—Influenza and Pneumococcal 
Immunization: A Qualitative Assessment of 
the Beliefs of Physicians and Older 
Hispanic Americans and African Americans
2003 18 in-depth interviews with physicians, including 
family medicine, internal medicine, cardiology 
and pulmonary medicine and 18 focus groups with 
adults 65 years old and older, including: 10 groups 
with African American adults and 8 groups with 
Hispanic American adults. Interviews and groups 
were conducted in Chicago, IL; Jackson, MS; 
Milwaukee, WI; Rochester, NY; San Antonio, TX
Surveys(S) S1—Knowledge, Attitudes and Beliefs: 
National Flu Survey
2012 A total of 12,082 interviews were completed for 
adults (9,791 from landline and 2,291 from 
cellular only/mainly households). The sample was 
a list-assisted RDD sample of both landline and 
cellular telephones. Interviews were conducted 
March 1 through March 29, 2011. Selected 
geographic areas were oversampled to achieve a 
higher representation of Hispanic, non-Hispanic 
black and non-Hispanic Asian. For the landline 
sample, selected counties were oversampled, and 
for the cellular phone sample, selected states were 
oversampled
S2—Testing of Influenza Vaccine PSA 
Concepts with Mothers: Topline Report
2008 Online surveys were conducted with 102 
individuals, while mall intercepts involved 101 
participants. All participants were mothers of 
children between 6 months and 18 years old. 
Study included evaluating two draft public service 
announcements designed to promote annual 
influenza vaccination for children. Mall intercept 
interviews were conducted in Atlanta, GA; 
Boston, MA; St. Louis, MO; and Portland, OR
Surveys(S) S3—Seasonal Influenza Survey Report—
January 2007
2007 A national survey of adults 18 years and older 
conducted using two modalities: a random-digit-
dialed (RDD) and web-based survey. A total of 
1247 interviews were obtained by RDD and 1290 
for Web
S4—Seasonal Influenza Survey Report—
August 2007
2007 A national survey of adults 18 years and older 
conducted using a web-based survey. In total, 
1,614 individuals participated in the study, 
including a main study sample of 1,353, along 
with two oversamples of African (n = 1139) and 
Hispanic Americans (n = 122)
S5—Childhood Influenza Immunization 
Survey Analytic Results for Pediatricians
2007 Telephone interviews with a random selected 
sample of 1200 pediatricians and 220 family 
practitioners
S6—Seasonal Flu Survey: 2006–2007 
Influenza Season: Logistic Regression 
Results: Vaccination Patterns in Households 
with a High-risk Member
2007 Telephone interviews with 1113 survey 
respondents from a national probability study. 475 
respondents lived in a household with an 
individual(s) with a chronic medical condition
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Research method(s) Study identifier and report title Report year Target audience(s) and methods summary
S7—Pediatric Influenza Survey Report 2003 A telephone administered survey completed with 
251 out of 282 qualified pediatricians. Potential 
survey respondents were randomly chosen from 
the American Medical Association masterfile. All 
were in active practice and provided on average 5 
vaccinations to at least five children less than 2 
years old each week
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Table 2
Major recurring themes studies involving general public and sub-populations of the public.
KAB-related recurring themes As exemplified by… Studies supporting theme
General public, parents and targeted 
sub-populations
Members of targeted public population 
groups have “basic but also quite 
limited influenza-related knowledge” 
with respect to influenza and influenza 
vaccine
• Most recognized that influenza was different and 
more serious than the “common cold”
• Most understood that influenza was contagious and 
transmitted in many ways, including coughing, 
sneezing, shaking hands, physical contact
Patients and parents associated influenza with body 
aches, cough, runny nose, fever, upset stomach—
but had difficulty differentiating influenza from 
other respiratory illnesses, including severe colds
• Some recognized a link with pneumonia, but few 
were knowledgeable about influenza-related 
hospitalizations or deaths
• Many adults did not appear to know there was a 
universal influenza vaccination recommendation 
(e.g., recent studies found many did not believe they 
were in a recommended group for vaccination)
• Influenza was associated with cold weather, 
including being caused or triggered by being 
improperly dressed in cold weather or going into 
cold weather with wet hair
FG1, FG2, FG3, FG4, FG5, 
FG6, FG7, FG8, FG9, FG11, 
FG12, IDI1, IDI2, IDI3, IDI5, 
IDIFG1, IDIFG4, S1, S3, S4
People 50 years old and older often had 
the best knowledge of influenza and flu 
vaccination recommendations
• They were usually aware that seasonal influenza 
may lead to severe health consequences such as 
pneumonia or death
• They perceived vaccination as the best prevention or 
protection against influenza
People 50 and older frequently were more or most 
concerned about getting the flu
FG2, FG3, FG5, FG6, FG11, 
FG12, IDIFG4, S3, S4
Knowledge of recently available 
influenza vaccine formulations and 
antivirals was limited
• Basic information needs appear to be high for 
quadrivalent, high-dose and nasal spray influenza 
vaccines, including the differences between the 
vaccines and which vaccines are most appropriate 
People were consistently interested in information 
about types of vaccines and mode of vaccination 
(e.g., vaccination vs. spray) and if some types/
modes of vaccination are more effective than others
• Many had little knowledge or understanding of 
antivirals, including what they do and when they 
should be used or taken
FG1, FG2, FG3, FG4, FG6, 
IDIFG1
Many do not perceive influenza as a 
likely or significant health threat, 
particularly if they do not have a health 
condition that may place them at risk 
for severe illness or complications
• Many did not believe they were likely or susceptible 
to contracting influenza or having a severe health 
outcome if they did, with about half of respondents 
in a national survey stating they were “not very” or 
“not at all concerned about getting seasonal 
influenza”
• Many believed there were deaths or cases of severe 
illness associated with influenza, but that those that 
primarily occurred among older people or people 
with weak/weakened immune systems
• Some believed absence of influenza illness (e.g., not 
having flu recently or at all) was a reason to avoid 
vaccination (e.g., “I'm doing fine without it,” or 
“Don't mess with a good thing”)
FG1, FG2, FG3, FG4, FG5, 
FG7, FG9, FG10, FG11, 
FG12, IDI1, IDI2, IDI3, 
IDIFG1, IDIFG4, S3
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KAB-related recurring themes As exemplified by… Studies supporting theme
• Young adults perceived influenza as a danger only 
to children and the elderly and assumed their 
immune systems could “fight off” influenza
• Many noted that if/when influenza was perceived to 
be more serious (e.g., a strain causing much disease 
or much serious illness) their interest in vaccination 
increased
Influenza was viewed negatively but 
also often perceived as a manageable 
disease—i.e., one that brings about 
symptoms and causes discomfort but 
doesn't result in need for medical care, 
hospitalization or death (e.g., “you get 
sick for days then recover”)
• Most people associated influenza with feeling bad 
and causing life disruptions (e.g., having to miss 
days of work or school), but were not particularly 
concerned about it
• People's beliefs and perceptions of influenza 
severity were often based on their overall health, the 
condition of their immune system and previous 
experience with influenza.
• Most did not view influenza as likely to cause 
serious illness or harm for most people; younger 
and healthy people characterized influenza as a 
“bad cold that lasts several days”
• Health status and age – i.e., being younger or being 
18 to 49 years old – were often associated with 
influenza being a manageable illness
• If people with chronic illnesses believed they were 
effectively managing their condition, they, too, 
often perceived influenza as a manageable illness
FG1, FG3, FG4, FG5, FG7, 
FG9, FG10, FG11, FG12, S1, 
IDI3, IDIFG1, IDIFG4
Beliefs about influenza were strongly 
shaped and influenced by personal 
experience with the disease
• Many said that despite not getting vaccinated, they 
did not believe they had ever contracted influenza
• The belief that vaccines can cause influenza, make 
one sick, or leave one susceptible to other flu-like 
illnesses persisted, and was often based on personal 
experiences or knowing of such an experience
• Personal experience with influenza shaped 
participants' beliefs regarding the severity and 
duration of seasonal flu
• Some noted that the experience of having influenza 
motivated them to get vaccinated in following years, 
while others noted that when they or a family 
member contracted influenza, it was a manageable 
or relatively mild course of illness
• Some noted that they knew of people who came 
down with a severe case of influenza
FG2, FG3, FG5, FG7, FG8, 
FG9, FG10, FG11, FG12, 
IDI1, IDI2, IDI5, IDIFG1, 
IDIFG4, S4
Those who get an annual flu 
vaccination did so because they 
believed the vaccine protected them 
from a significant health threat and/or 
illness
• Many cited belief that vaccination would prevent flu 
or reduce flu severity as their primary motivation 
for vaccination
• Many at-risk adults reported regularly getting an 
influenza vaccination to reduce their risk of 
contracting influenza or having severe illness
• Most mothers of young vaccinated children did so 
to protect their children from flu
• People who had contracted influenza often cited 
that experience as their reason for getting 
vaccinated
• Perception of being at increased risk for medical 
complications (e.g., as a result of a chronic health 
condition) motivated many, particularly those 60 
and older
FG2, FG3, FG5, FG6, FG8, 
FG9, FG10, FG11, IDI1, IDI3, 
IDIFG1, IDIFG4, S2, S4
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KAB-related recurring themes As exemplified by… Studies supporting theme
Influenza vaccination was often 
perceived as recommended for, or 
needed by, people who were 
susceptible to severe illness or 
complications – particularly those 50 
years old and older and those with 
weaker or weakened immune systems – 
or for people who needed or wanted to 
protect such people
• Individuals 50 and older or who had a chronic 
medical condition were most likely to report having 
received an influenza vaccination each year
• Surveys found most respondents between 18 and 49 
years old did not think they needed a flu vaccination
• HCP and general public often knew that older 
people (especially 65 years old and older), people 
with certain medical conditions, and more recently, 
young children, should receive a seasonal influenza 
vaccination
• As the recommendation has been broadened to 
encompass all people 6 months old and older, most 
still perceived influenza vaccination as 
recommended for, and needed by, groups listed 
above
• Living in a household containing a chronically ill 
person was the strongest predictor of whether or not 
a study participant had received a seasonal flu 
vaccination
FG1, FG3, FG5, FG8, FG9, 
FG10, FG12, IDI2, IDI3, 
IDIFG4, S3, S4, S6
People who were older or who had 
personal experience with severe 
influenza had highest levels of 
motivation and uptake for seasonal flu 
vaccine
• Many who had a previous or recent experience with 
severe influenza said they got vaccinated because 
they did not want to repeat the experience
• A strong predictor of vaccination was age, with 
many studies finding participants 65 years and older 
most likely to have gotten a seasonal influenza 
vaccination
• Most people 50 years old and older reported getting 
an influenza vaccination each year, with many 
indicating that they believe the vaccine worked 
effectively.
FG5, FG6, FG11, IDIFG1, 
IDIFG4, S3, S4, S6
People with chronic health conditions 
had relatively high and likely growing 
awareness, of the health threat posed by 
influenza and the value of seasonal flu 
vaccination
• At-risk adults expressed concern about contracting 
flu and experiencing severe illness or flu-related 
medical conditions
• Many with chronic conditions recognized their 
existing medical condition(s) could be aggravated 
by influenza, including more severe illness and a 
longer recovery time—and more appeared aware of 
the potential severity of influenza
• Most people with chronic conditions appear to be 
getting a seasonal influenza vaccination (e.g., 
around 66% in a 2007 survey)
FG1, FG3, FG4, FG5, FG6, 
FG12, IDIFG1, IDIFG4, S3, 
S4
Even if parents had low to moderate 
levels of personal concern about 
influenza they were worried about flu 
affecting their children, particularly 
parents of at-risk children
• Many mothers believed the flu vaccine to be 
effective and beneficial, with most mothers of 
young children indicating they did or planned to 
have their child receive a flu vaccination
• Parents believed risk for the flu varied depending on 
the health status and age of an individual, with 
children often recognized as at risk for contracting 
flu and missing school as a result of flu
• Many believed it more important for their children 
to be vaccinated than themselves
• Parents who had their at-risk children vaccinated 
were very likely to also have received a flu 
vaccination
FG3, FG4, FG5, FG6, FG7, 
FG9, S2, S3, S4, S6
A doctor or health care provider 
recommendation mattered—and HCPs 
were a trusted and relied upon source of 
information about influenza vaccination
• Most studies suggested or indicated a vast majority 
of respondents or participants believed information 
and advice from their doctor or other HCP mattered 
a lot
FG2, FG3, FG4, FG5, FG8, 
FG9, FG10, FG11, FG12, 
IDI1, IDI2, IDI5, IDIFG4, S1, 
S3, S4
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KAB-related recurring themes As exemplified by… Studies supporting theme
• Many cited a doctor's recommendation as their 
primary reason for influenza vaccination
• Many parents and mothers cited a doctor's 
recommendation as primary reason for their child's 
flu vaccination
• Even for participants who were skeptical of 
influenza vaccine, studies repeatedly found that 
most people and parents relied on their health care 
provider for vaccine recommendations and 
information
• Active information seeking for influenza and 
influenza vaccination information was often low
• Some noted that HCPs did not mention or 
recommend seasonal influenza vaccination—and a 
result, they did not get vaccinated
Convenience and easy access to flu 
vaccine mattered
• Many noted that they were more likely to get the 
vaccine if it was easily or readily available, e.g., in 
the workplace, at physicians' office
• Some who did not get vaccinated cited lack of easy 
access or inconvenience as reason
• Mothers who favored in-school influenza 
vaccination clinics cited convenience as biggest 
benefit
• Inability to afford the vaccine and lack of health 
insurance coverage were often noted as barriers
• Some stated difficulty finding the vaccine dissuaded 
them from getting vaccination
FG2, FG4, FG5, FG6, FG7, 
IDI1, IDI2, IDI3, S3, S4
Active promotion of influenza 
vaccination and educational materials 
helped—and was valued by HCPs
• One of the reasons some people reported they 
received a flu vaccination was because they had 
seen or received communication about the benefits 
or importance of the vaccine (e.g., visual displays, 
radio or TV public service announcements or 
advertisements)
• Some indicated that family members or friends 
convinced them to get vaccinated; others cited news 
stories
• Many participants in studies that tested materials 
(e.g., fact sheets)indicated they learned things about 
flu vaccine recommendations, effectiveness and 
antivirals, that they did not previously know (e.g., 
that quadrivalent flu vaccine was available, that they 
were in a group recommended for vaccination, that 
antivirals could treat influenza)
• In testing, Spanish-language materials helped 
increase knowledge and understanding of influenza 
and pneumococcal disease and vaccinations
• Physicians and HCPs highly valued patient-
education materials, particularly those that were 
brief, in lay person language and that include safety 
and benefit information
FG1, FG2, FG3, FG4, FG5, 
FG6, FG7, FG8, FG9, IDI1, 
IDI3, IDI4, IDI5, IDIFG1, 
IDIFG2, IDIFG4, S2
Many of those who did not get seasonal 
influenza vaccination did not believe 
they needed it
• The most often stated reason given by people who 
did not get a flu vaccination was “I don't think I 
need it”
• About half of the adults in a national survey who 
did not get a flu vaccination for themselves or their 
child felt they were unlikely to get sick from 
influenza, with many stating they “never get the flu” 
or were not in a high-risk or priority group
FG2, FG4, FG5, FG7, FG8, 
FG12, IDIFG1, S1, S3, S4
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KAB-related recurring themes As exemplified by… Studies supporting theme
• Healthy and adults aged 18-49 often did not 
perceive a need for seasonal flu vaccination and/or 
were unaware they were included in seasonal flu 
vaccination recommendations
• Some with chronic health conditions (e.g., heart 
disease, diabetes, asthma) were unaware these 
conditions placed them at higher risk for 
complications from influenza
Many who did not get seasonal 
influenza vaccinations did not believe 
the vaccine was effective—e.g., 
vaccination was not seen as providing 
much or good protection from influenza
• A substantial number of people (e.g., from 1 in 5 to 
1 in 3) in national surveys indicated they did not 
believe the vaccine would protect them from 
influenza
• The fact that the vaccine strains generally changed 
from year to year was a cause of concern for some 
(e.g., “it's an educated guess when it comes to flu 
vaccines”)
• Those who do not get seasonal influenza 
vaccinations for themselves or their children often 
had concerns about vaccine effectiveness
• People 65 and older who do not get influenza 
vaccination often believed risks associated with the 
vaccine (e.g., getting sick as a result of vaccination) 
outweighed the benefits (e.g. protection provided)
FG1, FG2, FG3, FG5, FG7, 
FG8, FG9, FG10, FG12, IDI2, 
IDIFG1, S1, S3, S4
Many, particularly those who did not 
get an annual flu vaccination, were 
fearful of the vaccine—e.g., they 
believed the vaccine brings tangible or 
likely risks
• Many, including some who routinely get a seasonal 
flu vaccination, believed seasonal influenza vaccine 
can cause or leave them susceptible to influenza
• Many were concerned that flu vaccines caused bad 
side effects or adverse reactions
• Many believed that they had become ill or gotten 
influenza after receiving an influenza vaccination
• Some were more afraid of the side effects of 
vaccine than of influenza (i.e., the disease)
• A few said they were afraid of needles, while some 
were concerned about how flu vaccine would 
interact with other medicines (e.g., antibiotics, 
prescription medications for chronic illnesses)
FG1, FG3, FG4, FG5, FG8, 
FG9, FG10, FG11, FG12, 
IDIFG1, IDIFG4, S2, S3, S4
Parents who did not get their children 
vaccinated believed influenza 
vaccinations were not effective—and/or 
that vaccination did not provide much 
or needed protection from influenza
• Some parents were concerned about bad reactions 
to the vaccine or the vaccine causing the flu.
• Some believed their child was not at risk for flu 
because he/she was around a lot of other children
• Some parents, including those who were otherwise 
following the recommended immunization schedule 
perceived the influenza vaccination as “optional” or 
“not unnecessary”
• Some mothers who did not currently have their 
children receive an influenza vaccination indicated 
they probably would once their children entered 
daycare or school because of increased exposure to 
other children and germs
FG3, FG4, FG5, FG6, FG7, 
FG9, S2, S3, S4
Beliefs about influenza vaccine 
effectiveness and safety were strongly 
influenced by personal experiences
• Participants who got influenza vaccinations often 
judged the effectiveness of the vaccine based on 
whether or not they got the flu that year.
• People and parents who did not get seasonal 
influenza vaccinations frequently cited personal 
effectiveness (e.g., “I got vaccinated and still got 
sick”) or perceptions related to illness causality 
(e.g., “the flu vaccine made me sick”) as reasons for 
not getting vaccinated
FG2, FG3, FG4, FG5, FG6, 
FG7, FG8, FG10, FG12, IDI1, 
IDIFG1, IDIFG4
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KAB-related recurring themes As exemplified by… Studies supporting theme
• Many cited people they knew as having gotten sick 
or the flu shortly after getting an influenza 
vaccination, with some reporting people who 
received the vaccine came down with severe cases 
of influenza after receiving the vaccine
• Many recollected hearing “reports” of vaccine-
related adverse events
Many, including those who get seasonal 
flu vaccinations, believed there were 
other effective ways to prevent 
influenza—and for some, these were 
more effective than vaccination
• Washing hands often, eating healthy, taking 
vitamins, being active, avoiding sick or ill people, 
using anti-bacterial wipes and disinfectants to clean 
surfaces, staying well rested, getting enough sleep, 
dressing properly for cold weather were cited by 
many as effective ways to prevent influenza
• Mothers who were comfortable with flu vaccination 
for their children reported more relying more 
heavily on non-pharmaceutical measures such as 
hand washing to protect themselves and their 
families from influenza than on flu vaccine
• Many participants reported being more “vigilant” 
about hand washing, use of hand sanitizers, and 
coughing into one's elbow during the 2009 H1N1 
pandemic
FG1, FG3, FG5, FG7, FG8, 
FG12, IDI2, IDI3, IDIFG1, 
IDIFG4
Many people, including HCPs and 
those who received seasonal flu 
vaccinations, stated an interest in 
information on influenza vaccine 
efficacy, safety, side effects and adverse 
events
• Parents commonly indicated wanting more 
information about the side effects of flu vaccines, 
including the side effects associated with different 
types of influenza vaccines
• Many, especially those who do not get a seasonal 
flu vaccination, were concerned or fearful of side 
effects or adverse reactions from influenza vaccines
• Many HCPs, particularly nurses, want more 
information on vaccine efficacy and safety.
FG3, FG4, FG5, FG8, FG10, 
FG12, IDIFG1
Some messaging concepts and 
messages appeared to resonate better 
than others
• Many adults reacted positively to messages that 
stressed prevention or encouraged vaccination as a 
way to be proactive or have control over their health 
(e.g., “empowering,” “flu vaccination being part of 
a healthy lifestyle”)
• People with chronic health conditions appeared to 
respond favorably to messages and materials that 
helped them understand their increased risk or why 
they were at risk
• Messages that address misperceptions related to the 
influenza vaccines causing flu or flu-like symptoms 
may be effective (e.g., addressing why such 
symptoms may occur, informing people that the 
vaccine does not cause influenza)
• Many responded favorably to messages involving 
the concept of getting a flu vaccination as a way to 
protect loved ones or community members
• Messages – especially recommendations – from 
HCPs, were often perceived positively
• Most people or parents were not aware of or did not 
understand the different types of influenza vaccines 
and were unfamiliar with flu and flu vaccine viruses 
and technical terms, such as “quadrivalent” or 2009 
H1N1
• Parents/mothers found reminders and messages that 
the flu can be a lot worse than they think or that the 
vaccine helped protect family members were 
persuasive
FG2, FG3, FG5, FG7, FG8, 
FG9, FG10, FG12, IDI5, 
IDIFG1, IDIFG4, S2
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KAB-related recurring themes As exemplified by… Studies supporting theme
• Messages that emphasized hospitalizations and 
deaths increased attention but did not appear to be 
motivating (e.g., statistics were seen as “hype” or as 
not likely to happen)
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Table 3
Major Recurring Themes Studies involving Health Care Providers and Professionals.
KAB-related Recurring Themes As exemplified by… Studies related to theme
Health Care Providers and Professionals (HCPs)
Influenza immunization-related knowledge 
and support among HCP was often highest 
among physicians, with members of other 
groups having knowledge similar to 
patients and parents
• There was high awareness of influenza vaccination 
recommendations for those who are older, have 
chronic health conditions or weaker immune systems 
and young children
• Most pediatricians reported having high awareness 
and fairly good or very good knowledge of seasonal 
flu vaccination recommendations for children
• Most physicians proactively offered influenza 
vaccination to children but some skepticism or 
concerns existed regarding the effectiveness of the 
vaccine (e.g., many noted that efficacy can and does 
vary depending on the vaccine's matching with 
circulating viruses)
• Physician awareness of antivirals appears relatively 
high—though many have little experience prescribing 
them
• Some physicians may not yet be aware of some 
groups at high risk for flu complications, such as 
American Indians/Alaska Natives and the morbidly 
obese
• Physicians were supportive of universal influenza 
vaccination recommendation and noted it simplified 
office protocols
FG10, IDI1, IDI3, 
IDIFG1, IDIFG2, 
IDIFG3, IDIFG4, S5, S7
Many did not perceive influenza as a 
serious health threat to most members of 
the general population—rather, it was 
primarily seen as a threat to those who 
were older or who had health conditions 
that made them susceptible to medical 
complications or severe illness
• Physicians, including specialists, recognized that 
influenza can be a potentially serious illness for 
people 65 years old and older, who have chronic 
health conditions, or who have weakened immune 
systems but often perceived influenza as a modest or 
manageable illness for others
• A number of physicians reported promoting influenza 
vaccination more aggressively to high-risk patients 
than other patients (e.g., reminding them throughout 
the year about flu vaccination)
• Many physicians indicated that influenza vaccination 
was the patient or parent's choice and were reluctant 
to be “pushy” or too strong in their efforts
FG10, IDI1, IDI4, 
IDIFG1, IDIFG3, S7
Many did not perceive influenza as a likely 
or significant health threat to themselves
• It was often expressed that influenza was primarily a 
threat to the very young, the elderly and people with 
certain chronic health conditions
• Many associated minimal consequences with 
contracting influenza (e.g., “I can handle flu,” “I'm 
not afraid of flu”)
• Some took comfort in the fact that influenza routinely 
caused illness (e.g., “People get flu all the time.”)
FG10, IDI4, IDIFG3
Influenza was often perceived as a 
manageable disease—for both themselves 
and most members of the general 
population
• Many expressed the belief that “If you take care of 
yourself, you shouldn't get very sick from influenza”
• Health care workers' decisions regarding flu 
vaccination were often based heavily on a personal 
risk-benefit analysis, with some noting that those 
with a healthy or strong immune system did not need 
a vaccination (e.g., “If your body is in good shape, 
you can heal yourself”)
FG10, IDI4, IDIFG2, 
IDIFG3
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KAB-related Recurring Themes As exemplified by… Studies related to theme
Many health providers, especially 
physicians, recognized that influenza 
posed a potentially serious health threat to 
some groups, including young children
• Nearly all physicians routinely offered influenza 
vaccination to children who have a high risk medical 
condition such as asthma as well as healthy 
household contacts of such children
• Some nurses indicated that influenza vaccinations 
were important for “older nurses”
IDI1, IDI3, IDIFG2, 
IDIFG3, S5, S6, S7
Some health care providers, including 
physicians, did not believe influenza was a 
serious health threat to most children
• Influenza was characterized as “not a concern” and 
influenza vaccination was seen as “optional” or “not 
necessary.”
• Healthy, older children were seen as able to handle 
influenza
• Some physicians characterized influenza as one of 
the less important childhood vaccinations
IDI4, IDIFG3
Many HCPs, particularly nurses, did not 
see a need for influenza vaccination for 
themselves
• Many HCPs cited being “already healthy” and/or 
“not at risk” as reasons for not getting an influenza 
vaccination.
• HCPs expressed belief that universal 
recommendation would have little or no effect on 
their interest in seasonal influenza vaccination.
• Many believed that they never had contracted 
influenza, so therefore it was not a threat to them.
• Some clinical personnel believed they had developed 
strong or stronger immune systems as a result of 
constant exposure to a variety of germs, including 
influenza
FG10, IDIFG2, IDIFG3
Most physicians believed influenza 
vaccination to be highly effective, while 
many other HCPs, particularly nurses, 
believed influenza vaccinations were 
(often) not effective—and/or that 
vaccination did not provide much or good 
protection from influenza
• The majority of physicians appeared to believe that 
flu vaccination was effective in preventing influenza 
illness—with many estimating effectiveness to be 
quite high
• Resistance to influenza vaccination was often 
characterized by a pronounced lack of trust in the 
vaccine, particularly its effectiveness
• Large numbers of both clinical and service workers 
cited getting flu from the vaccine, side effects, 
allergic reactions, and being left vulnerable to other 
illnesses as reasons for not getting an influenza 
vaccination
• Some nurses believed that a past influenza 
vaccination resulted in them being ill or getting 
influenza (e.g., “I did it once five years ago and got 
sick” or “I still got sick”)
• The fact the vaccine strains may not match the 
circulating influenza strains engendered skepticism 
among some, including among physicians
FG10, IDIFG1, IDIFG2, 
IDIFG3, IDIFG4
Vaccinated HCPs appeared to be more 
knowledgeable about influenza and 
influenza vaccination than non-vaccinated 
HCPs
• Those who receive seasonal influenza vaccinations 
appear more aware of the potential harms that 
influenza can cause, the threat that influenza poses to 
patients, and the ways influenza is transmitted
• Many unvaccinated HCPs do not appear to know that 
they are in a group for whom vaccination is 
recommended
• Some unvaccinated HCPs believe they have strong or 
stronger immune systems because of their workplace 
exposure to germs and disease
FG10, IDI4, IDIFG2
Many nurses and allied health 
professionals were more motivated by the 
• Some believed or seem to believe that they were very 
unlikely to transmit influenza to patients (e.g., “It's 
FG10, IDIFG2, IDIFG3
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KAB-related Recurring Themes As exemplified by… Studies related to theme
personal protection influenza vaccination 
may provide than by the patient protection 
it may provide
getting influenza from them, not giving it to them” 
that is motivation for vaccination)
• Many HCPs noted that “you've got to take care of 
yourself first” or getting vaccinated was a way to 
protect their family members (e.g., “You don't want 
to bring flu home”)
• Service workers regularly cited lost work days and 
associated lost pay as an incentive for influenza 
vaccination
Convenience and easy access to flu vaccine 
and flu vaccine-related educational 
materials and resources mattered
• Many HCPs noted that ease of access to the vaccine, 
particularly at their work places, was critical to their 
decision to obtain the vaccine
• HCPs have limited time for patient education or 
lengthy conversations so education materials and 
resources that are easy to use are helpful
FG10, IDI1, IDI4, IDI6, 
IDIFG1, IDIFG3
Some HCPs were or remain unconvinced 
of the value and need for seasonal 
influenza vaccinations.
• There were a substantial number of health care 
workers for whom traditional education and appeals 
have not been effective (e.g., they did not believe they 
were at risk for flu, they did not believe they put 
patients at risk for flu)
• Many HCPs, particularly nurses, believed working 
with sick patients and other preventive measures were 
as or more effective than vaccination
FG10, IDI1, IDI3, IDI6, 
IDIFG2, IDIFG3
HCPs believed public, sub-population and 
parent demand was important when it 
comes to providing flu vaccination
• Many HCPs believed that vaccination was the 
patient's choice and that greater patient awareness 
and knowledge about vaccines fostered interest (e.g., 
greater awareness led to greater demand)
• Most pediatricians said that parents' asking for 
influenza vaccine was an important factor in 
providing flu vaccine to children
IDI0, IDI4, IDIFG2, 
IDIFG3 S7
The time available for HCPs, particularly 
physicians and specialists, to discuss 
influenza vaccination was quite limited
• Physicians and specialists noted they have competing 
medical priorities and other time constraints, which 
left little time for lengthy conversations regarding 
influenza vaccination
• Doctors consistently noted that their time with 
patients with quite limited—many noted that while 
they recommend flu vaccination they quickly moved 
on if patients did not accept the advice
IDI0, IDI4, IDIFG2, 
IDIFG4
Some messaging concepts and messages 
appeared to resonate better than others
• Many believed the most effective messages were 
those tailored to specific patient or parent's questions, 
medical/health conditions, and situations
• Many noted that patient materials need to be simple, 
concise, and easy to read and understand
• Some HCPs said there was not enough detailed 
information focused specifically toward their 
profession with respect to influenza (e.g., how 
influenza affects HCPs, documented evidence of how 
the vaccine can protect them)
• Physicians noted that informing patients that 
influenza could cause pneumonia often motivated 
vaccination
• Many HCPs believed it important to provide or 
highlight information and data that illustrated the 
safety of the vaccine, including addressing myths and 
misperceptions people have about the vaccine
FG10, IDI1, IDI4, IDI6, 
IDIFG4
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KAB-related Recurring Themes As exemplified by… Studies related to theme
• Some said “active promotion” is necessary or 
beneficial when it comes to increasing HCPs' 
influenza vaccination
More and ongoing public and patient 
education is needed to foster influenza 
vaccine demand and uptake
• Physicians noted that patient awareness affected 
demand for influenza vaccination and there was a 
need for proactive campaigns that promoted the 
benefits of vaccines
• Many believed public and patient messages and 
materials needed to call attention to people at highest 
risk for influenza complications and that flu 
potentially affects many people each year
• Some believed that positive, rather than negative 
messages, were or would be most effective with 
public and parents (e.g., highlighting benefits of 
vaccination rather than highlighting negative 
consequences of flu or making people feel guilt if 
they did not get themselves or child vaccinated), 
while others favored messages that put the emphasis 
on potential harm brought by influenza
• Many noted that messages tailored to patient or 
parent concerns were effective–as was letting patients 
or parents know that the HCP had been vaccinated
IDI1, IDI4, IDIFG2
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Table 4
SHARE Framework.
• Share the reasons why the recommended vaccine is right for each patient based on his or her health status and risk factors
• Highlight positive personal experiences with vaccination
• Address patient questions and any concerns about adult vaccines, including safety and effectiveness, in plain and understandable 
language
• Remind patients that vaccine-preventable diseases still exist in the U.S. and can be serious for them as well as for friends and 
family members
• Explain the potential costs of getting disease, including serious health effects, time lost (missing work, activities, and family 
events) and financial costs
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